Voximetry, founded in Madison, WI in 2016, is an early stage healthcare technology company that specializes in commercializing improvements related to nuclear medicine dosimetry. Voximetry’s patient-specific approach can accurately predict efficacy and adverse effects of radiopharmaceutical therapy, thereby improving patient outcomes. Voximetry leverages intellectual property developed at the University of Wisconsin - Madison, which has a rich history of fostering successful biotechnology companies.
11/9/2020 - Voximetry and the Imaging and Radiation Oncology Core (IROC) have reached agreement to evaluate the role of dosimetry in alpha- and beta-emitting Radiopharmaceutical Therapy (RPT) clinical trials. Read more>>
11/3/2020 - Sankara Hari Gopalakrishnan has joined Voximetry as a Senior Software Engineer for Image Processing and Optimization Algorithms. He will be advancing Voximetry's Torch software in the areas of deformable registration, contour propagation, and optimization. Read more>>
10/15/2020 - Voximetry has been awarded a Phase II Small Business Innovation Research (SBIR) grant valued at $1.8 million from the National Cancer Institute (NCI). This award will assist Voximetry in commercializing its Torch software for RPT treatment planning. Read more>>
Copyright © 2020 Voximetry Inc. - All Rights Reserved.